Wellgistics Health Secures $6.5M Capital, Refinances All Convertible Debt, Enabling Key Merger
WGRX sits 40% above its 52-week low of $3.04 on light trading volume (0.2× avg).
Summary
Wellgistics Health secured $6.5 million in new capital and refinanced all existing convertible debt, a move critical for its survival and to close a major merger, despite significant dilution.
Key Events · Financing and Capital Events · WGRX
-
Secured $6.5 Million in New Capital
The company raised $6.5 million in fresh capital, which is equivalent to 100% of its current market capitalization, providing a critical financial lifeline.
-
Refinanced All Convertible Debt
All outstanding convertible debt was refinanced with a new $21 million instrument, cleaning up the balance sheet.
-
Oversubscribed Offering with Premium Pricing
The offering was oversubscribed, and the new convertible debt converts at $6.00 per share (above the current $4.25 market price), with subsequent preferred stock converting at $50.00 per share, indicating institutional confidence despite the company's distress.
-
Enables DelivMeds AI Transaction
The new capital satisfies a key closing condition for the previously announced binding letter of intent for the DelivMeds AI Transaction.
Analysis · WGRX · Trade & Services
This 8-K/A provides the definitive terms for a critical financing event. Wellgistics Health, a company facing severe financial distress, successfully raised $6.5 million in new capital and refinanced all of its outstanding convertible debt. The offering was oversubscribed, and the new convertible debt converts at $6.00 per share, which is above the current market price of $4.25. Additionally, the preferred stock into which the debt will convert has a $50.00 conversion price. This capital infusion, equivalent to 100% of the company's market capitalization, is a significant lifeline, addressing a "going concern" warning and satisfying a closing condition for the previously announced DelivMeds AI Transaction. While highly dilutive, the successful execution of this financing at a premium to market indicates institutional confidence and provides crucial runway for the company's survival and strategic initiatives.
How filings like this one have moved
In the 30 days to Oct 3, 2026, 41% of the 324 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.33%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, WGRX was trading at $4.25 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $6.5M. The 52-week trading range was $3.04 to $104.74. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.